Variant report
Variant | nsv947458 |
---|---|
Chromosome Location | chr1:189588116-189591869 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573045486 | chr1:189588123-189588124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545204029 | chr1:189588172-189588173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558927684 | chr1:189588245-189588246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1976438 | chr1:189588249-189588250 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs183108052 | chr1:189588275-189588276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150844388 | chr1:189588296-189588297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139579301 | chr1:189588329-189588330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558230508 | chr1:189588337-189588338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1566679 | chr1:189588348-189588349 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs560337236 | chr1:189588362-189588363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73049569 | chr1:189588381-189588382 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs149286239 | chr1:189588385-189588386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562888021 | chr1:189588411-189588412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537777501 | chr1:189588504-189588505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550068614 | chr1:189588557-189588558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188129091 | chr1:189588639-189588640 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1033840 | chr1:189588660-189588661 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs2134368 | chr1:189588688-189588689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538843641 | chr1:189588707-189588708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192071875 | chr1:189588714-189588715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568328156 | chr1:189588724-189588725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534320707 | chr1:189588739-189588740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376057055 | chr1:189588783-189588784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566394061 | chr1:189588796-189588797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184425358 | chr1:189588820-189588821 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1393500 | chr1:189588831-189588832 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs113618536 | chr1:189588840-189588841 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1033841 | chr1:189588898-189588899 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs1033842 | chr1:189588914-189588915 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs112602097 | chr1:189588930-189588931 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575498715 | chr1:189588936-189588937 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs16830966 | chr1:189588949-189588950 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs554568608 | chr1:189588985-189588986 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574326478 | chr1:189589048-189589049 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374700260 | chr1:189589106-189589107 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77202768 | chr1:189589108-189589109 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559853822 | chr1:189589153-189589154 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576524916 | chr1:189589176-189589177 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147431350 | chr1:189589181-189589182 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74138445 | chr1:189589199-189589200 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs139762326 | chr1:189589207-189589208 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112870665 | chr1:189589232-189589233 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548571301 | chr1:189589237-189589238 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116124040 | chr1:189589254-189589255 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527721660 | chr1:189589259-189589260 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192366969 | chr1:189589279-189589280 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10489759 | chr1:189589339-189589340 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
48 | rs539895528 | chr1:189589370-189589371 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs80295109 | chr1:189589407-189589408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2038651 | chr1:189589427-189589428 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:189586400-189588800 | Weak transcription | HMEC | breast |
2 | chr1:189586400-189589000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr1:189586600-189588600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr1:189587000-189588200 | Weak transcription | A549 | lung |
5 | chr1:189587000-189588600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr1:189588200-189588800 | Enhancers | A549 | lung |
7 | chr1:189588600-189589600 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr1:189588600-189589600 | Enhancers | HUVEC | blood vessel |
9 | chr1:189588600-189589800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr1:189588800-189589000 | Active TSS | A549 | lung |
11 | chr1:189588800-189589400 | Enhancers | NHEK | skin |
12 | chr1:189588800-189589800 | Enhancers | HMEC | breast |
13 | chr1:189589000-189589400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
14 | chr1:189589000-189589400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr1:189589000-189589400 | Flanking Active TSS | A549 | lung |
16 | chr1:189589000-189589400 | Enhancers | Hela-S3 | cervix |
17 | chr1:189589000-189589400 | Enhancers | NH-A | brain |
18 | chr1:189589000-189589400 | Enhancers | Osteobl | bone |
19 | chr1:189589400-189589800 | Enhancers | A549 | lung |
20 | chr1:189589400-189593200 | Weak transcription | Hela-S3 | cervix |
21 | chr1:189589800-189597800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
22 | chr1:189589800-189598000 | Weak transcription | HMEC | breast |